Sleep Consolidation Therapy for Insomnia Study
- Conditions
- Insomnia symptomsMental Health - Other mental health disorders
- Registration Number
- ACTRN12618001668291
- Lead Sponsor
- Woolcock Institute of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 141
Aged 18-65 years. Able to provide informed consent. English language. Symptoms of insomnia (ISI>15). Access to a smartphone.
Pregnancy (self-reported). Shift workers. Significant medical conditions likely to either prevent use of App or be exacerbated by sleep restriction (epilepsy, bipolar disorder, heart failure). Self-reported suicidal ideation. Recent travel (destination with more than a 2 hour time difference within last 1 month). Travel during study (destination with more than an hour time difference)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insomnia symptoms will be measured using the Insomnia Severity Index (ISI).[Measurements to assess the primary outcome will be at baseline and week 6]
- Secondary Outcome Measures
Name Time Method